How to Administer Methotrexate Injection Intravenously
For IV methotrexate administration, reconstitute the lyophilized powder immediately prior to use with sterile, preservative-free medium (5% Dextrose or 0.9% Sodium Chloride) to appropriate concentration, then administer via IV infusion with mandatory hydration, urinary alkalinization, and leucovorin rescue for high-dose regimens 1.
Reconstitution and Preparation
Reconstitute immediately before use:
- Use sterile, preservative-free medium (5% Dextrose Solution or Sodium Chloride Injection)
- For 1 gram vials: reconstitute with 19.4 mL to achieve 50 mg/mL concentration
- For high-dose IV infusion: dilute total dose in 5% Dextrose Solution
- Critical warning: Do NOT use preserved formulations for high-dose or intrathecal therapy due to benzyl alcohol content 1
Administration Routes and Dosing by Indication
For Rheumatoid Arthritis/Inflammatory Conditions
- Start with oral route first (conditionally recommended over subcutaneous) 2
- IV route is typically reserved for patients who fail oral therapy or have absorption issues
- Target dose: 15 mg/week within 4-6 weeks of initiation 2
- Weekly dosing schedule only—never daily 3
For Oncologic Indications (High-Dose Methotrexate)
Standard high-dose protocol 1:
Pre-hydration (mandatory):
- Administer 1,000 mL/m² IV fluid over 6 hours BEFORE starting methotrexate
- Continue hydration at 125 mL/m²/hr (3 liters/m²/day) during infusion
- Maintain hydration for 2 days after infusion completion
Urinary alkalinization (mandatory):
- Maintain urine pH >7.0 throughout infusion and leucovorin therapy
- Use sodium bicarbonate (oral or IV in separate solution)
Methotrexate infusion:
Mandatory Monitoring for High-Dose IV Methotrexate
Critical monitoring schedule 1:
- Baseline: Complete blood count, renal function (creatinine), liver function tests
- 24 hours post-infusion: Serum creatinine AND serum methotrexate level
- Daily thereafter: Continue monitoring until methotrexate level <0.05 µmol/L (5 x 10⁻⁸ mol/L)
Methotrexate Level Thresholds and Actions
| Timepoint | Methotrexate Level | Action Required |
|---|---|---|
| 24 hours | ≥50 µmol/L | Delayed elimination—increase leucovorin to 150 mg IV q3h [1] |
| 48 hours | ≥5 µmol/L | Delayed elimination—increase leucovorin [1] |
| 72 hours | >0.2 µmol/L | Continue leucovorin 15 mg q6h until <0.05 µmol/L [1] |
| 96 hours | >0.05 µmol/L | Continue leucovorin until target reached [1] |
Leucovorin Rescue Protocol (Mandatory for High-Dose)
Standard rescue 1:
- Begin 24 hours after START of methotrexate infusion
- Dose: 15 mg PO/IM/IV every 6 hours for 60 hours (10 doses total)
- Do NOT administer leucovorin intrathecally 1
For delayed elimination:
- If creatinine doubles at 24 hours OR methotrexate levels remain elevated: escalate to 150 mg IV every 3 hours 1
- Consider hemodialysis with high-flux dialyzer for severe cases 1
Critical Safety Considerations
Pre-administration requirements 3, 1:
- Verify adequate renal function (adjust dose for creatinine clearance impairment)
- Check for pleural effusions or ascites (third-space fluid delays clearance) 6
- Review all concomitant medications for interactions (NSAIDs, proton pump inhibitors, penicillins can impair clearance)
- Ensure patient is well-hydrated before starting
Common pitfalls to avoid:
- Never confuse weekly with daily dosing—this is a fatal error
- Never use preserved formulations for high-dose therapy
- Never skip urinary alkalinization for high-dose regimens
- Never delay leucovorin rescue beyond 24 hours for high-dose protocols
- Always maintain adequate urine output (>100 mL/hour) 6
Toxicity warning signs requiring immediate intervention 3:
- Fever/flu-like illness
- Mouth ulceration
- Unexplained bruising or bleeding
- Nausea, vomiting, abdominal pain, dark urine
- Breathlessness or cough
The evidence strongly supports that proper hydration, alkalinization, and leucovorin rescue are non-negotiable for high-dose IV methotrexate to prevent life-threatening toxicity, particularly irreversible renal failure 1, 6.